 |
 |
|
|
|
| Repaglinide |
 |
| Repaglinide |
 |
| 135062-02-1 |
 |
| Anti-diabetic drugs. Non-sulfonylurea oral hypoglycemic agents for the treatment of type ¥± diabetes |
 |
Repaglinide
English Synonyms: AG-EE-623
2-ETHOXY-4-[2-[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID
REPAGLINIDE
(S)-2-ETHOXY-4-(2-(3-METHYL-1-(2-(PIPERIDIN-1-YL)PHENYL)BUTYLAMINO)-2-OXOETHYL)BENZOIC ACID
(S)-(+)-2-ETHOXY-4-[N-[1-(2-PIPERIDINOPHENYL)-3-METHYL-1-BUTYL]AMINOCARBONYLMETHYL]BENZOIC ACID
NOVONORM
PRANDIN
ag-ee388zw
CAS NO.: 135062-02-1
Assay: 98%
Molecular Formula:C27H36N2O4
Molecular Weight:452.59
Specifications: EP6
Packing:1kg/foil bag
Appearance: White crystalline powder, odorless
Usage:Anti-diabetic drugs. Non-sulfonylurea oral hypoglycemic agents for the treatment of type ¥± diabetes
Email£ºycgsales02@yccreate.com
Phone:86-27-68886667 Tax:86-27-880480 |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
